Charles Venuto

Charles Venuto

UNVERIFIED PROFILE

Are you Charles Venuto?   Register this Author

Register author
Charles Venuto

Charles Venuto

Publications by authors named "Charles Venuto"

Are you Charles Venuto?   Register this Author

31Publications

906Reads

26Profile Views

Inflammation investigated as a source of pharmacokinetic variability of atazanavir in AIDS Clinical Trials Group protocol A5224s.

Antivir Ther 2018 ;23(4):345-351

AIDS Clinical Trials Group Pharmacology Specialty Laboratory, New York State Center of Excellence in Bioinformatics and Life Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3851/IMP3209DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5967996PMC
September 2019

Efavirenz Therapeutic Range in HIV-1 Treatment-Naive Participants.

Ther Drug Monit 2017 12;39(6):596-603

*AIDS Clinical Trials Group Pharmacology Specialty Laboratory, New York State Center of Excellence in Bioinformatics and Life Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, New York; †Center for Human Experimental Therapeutics, University of Rochester, Rochester, New York; ‡Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center and the University of California, Los Angeles, California; §Division of Infectious Diseases and Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; ¶University of Miami School of Medicine, Miami, Florida; ‖University of Washington School of Medicine and Harborview Medical Center, Seattle, Washington; **ViiV Healthcare, Research Triangle Park, North Carolina; ††Statistical Data Analysis Center, Harvard T. H. Chan School of Public Health, Boston, Massachusetts; and ‡‡Department of Biostatistics, University at Buffalo, Buffalo, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FTD.0000000000000443DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718358PMC
December 2017

Bone mineral density reductions after tenofovir disoproxil fumarate initiation and changes in phosphaturia: a secondary analysis of ACTG A5224s.

J Antimicrob Chemother 2017 07;72(7):2042-2048

Department of Pediatrics, Case Western Reserve University and University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dkx076DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890741PMC
July 2017

Paritaprevir and Ritonavir Liver Concentrations in Rats as Assessed by Different Liver Sampling Techniques.

Antimicrob Agents Chemother 2017 05 24;61(5). Epub 2017 Apr 24.

Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University at Buffalo, Buffalo, New York, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.02283-16DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404580PMC
May 2017

Multiphenotype association study of patients randomized to initiate antiretroviral regimens in AIDS Clinical Trials Group protocol A5202.

Pharmacogenet Genomics 2017 03;27(3):101-111

aThe Center for Systems Genomics, The Huck Institutes of the Life Sciences, The Pennsylvania State University, University Park bBiomedical and Translational Informatics, Geisinger Health System, Danville, Pennsylvania cLos Angeles Biomedical Research Institute at Harbor, UCLA Medical Center, Torrance, California dUniversity of Rochester Medical Center, Rochester eDepartment of Pharmacy Practice, Center for Integrated Global Biomedical Sciences, University at Buffalo, SUNY, Buffalo, New York fVanderbilt University School of Medicine gMeharry Medical College, Nashville, Tennessee, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000263DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5285297PMC
March 2017

Intrahepatic Sampling for the Elucidation of Antiviral Clinical Pharmacology.

Clin Pharmacol Drug Dev 2017 Mar;6(2):169-175

Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University at Buffalo, Buffalo, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpdd.311DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859954PMC
March 2017

Assessment of Hepatic Impairment and Implications for Pharmacokinetics of Substance Use Treatment.

Clin Pharmacol Drug Dev 2017 Mar;6(2):206-212

Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpdd.336DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859945PMC
March 2017

Pharmacokinetic Considerations for Combining Antiretroviral Therapy, Direct-Acting Antiviral Agents for Hepatitis C Virus, and Addiction Treatment Medications.

Clin Pharmacol Drug Dev 2017 Mar;6(2):135-139

AIDS Clinical Trials Group Pharmacology Specialty Laboratory, New York State Center of Excellence in Bioinformatics and Life Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpdd.313DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341144PMC
March 2017

Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders.

Curr Vasc Pharmacol 2016 ;14(3):280-7

Translational Pharmacology Research Core Center of Excellence in Bioinformatics and Life Sciences Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences University at Buffalo, Buffalo, NY 14214, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879810PMC
December 2016

A review of disease progression models of Parkinson's disease and applications in clinical trials.

Mov Disord 2016 07 26;31(7):947-956. Epub 2016 May 26.

Center for Human Experimental Therapeutics, University of Rochester, Rochester, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.26644DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931998PMC
July 2016

Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.

Pharmacogenet Genomics 2015 Sep;25(9):450-61

aDepartments of Biostatistics bDepartment of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee cUniversity of Rochester Medical Center, Center for Human Experimental Therapeutics, Rochester dDepartment of Pharmaceutical Sciences, University at Buffalo, SUNY, Buffalo, New York eDepartment of Pharmacology and Toxicology, University of Alabama at Birmingham, School of Medicine, Birmingham, Alabama fDepartment of Medicine, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California gCase Western Reserve University, Department of Epidemiology and Biostatistics, Cleveland, Ohio, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=01213011-201509000-000
Publisher Site
http://dx.doi.org/10.1097/FPC.0000000000000156DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522226PMC
September 2015

Pharmacokinetics of ε-Aminocaproic Acid in Neonates Undergoing Cardiac Surgery with Cardiopulmonary Bypass.

Anesthesiology 2015 May;122(5):1002-9

From the Departments of Anesthesiology (M.P.E., D.M.S.), Surgery (G.M.A., R.E.A.), Pediatrics (J.M.C.), and Neurology, Center for Human Experimental Therapeutics (C.V.), University of Rochester School of Medicine and Dentistry, Rochester, New York; and Department of Anaesthesiology, University of Auckland, Auckland, New Zealand (B.A.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/ALN.0000000000000616DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882606PMC
May 2015

Novel methods and technologies for 21st-century clinical trials: a review.

JAMA Neurol 2015 May;72(5):582-8

Department of Neurology, University of Rochester Medical Center, Rochester, New York2Center for Human Experimental Therapeutics, University of Rochester Medical Center, Rochester, New York4Clinical and Translational Sciences Institute, University of Roche.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaneurol.2014.4524DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708881PMC
May 2015

Recent advances in management of the HIV/HCV coinfected patient.

Future Virol 2015;10(8):981-997

Pharmacy Practice (Medicine and Pediatrics), School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, 285 Kapoor Hall, Buffalo, New York 14214, USA; New York State Center of Excellence in Bioinformatics and Life Sciences, University at Buffalo, 701 Ellicott Street, Buffalo, New York 14203, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fvl.15.64DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751983PMC
January 2015

Genomewide association study of atazanavir pharmacokinetics and hyperbilirubinemia in AIDS Clinical Trials Group protocol A5202.

Pharmacogenet Genomics 2014 Apr;24(4):195-203

aDepartment of Medicine bDepartments of Pharmacology, Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee cThe Center for Human Experimental Therapeutics, University of Rochester Medical Center, Rochester dTranslational Pharmacology Research Core, University at Buffalo, SUNY, Buffalo, New York eDepartment of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, Pennsylvania fDepartment of Medicine, Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, California, USA gDepartment of Life Sciences, The Swiss Institute of Technology hDepartment of Microbiology, University Hospital, University of Lausanne, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=01213011-201404000-000
Publisher Site
http://dx.doi.org/10.1097/FPC.0000000000000034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4059003PMC
April 2014

Oral ketamine for children with chronic pain: a pilot phase 1 study.

J Pediatr 2013 Jul 10;163(1):194-200.e1. Epub 2013 Feb 10.

Departments of Pediatrics and Neurosciences, Medical University of South Carolina, Charleston, SC 29425, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpeds.2012.12.077DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799772PMC
July 2013

Pharmacologic approaches to the treatment of Huntington's disease.

Mov Disord 2012 Jan 13;27(1):31-41. Epub 2011 Oct 13.

Center for Human Experimental Therapeutics, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.23953DOI Listing
January 2012

TRACK-HD: both promise and disappointment.

Lancet Neurol 2012 Jan 2;11(1):24-5. Epub 2011 Dec 2.

Center for Human Experimental Therapeutics, University of Rochester Medical Center, Rochester, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1474-4422(11)70285-XDOI Listing
January 2012

Therapeutic drug monitoring of protease inhibitors and efavirenz in HIV-infected individuals with active substance-related disorders.

Ther Drug Monit 2011 Jun;33(3):309-14

Translational Pharmacology Research Core, NYS Center of Excellence in Bioinformatics and Life Sciences, Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, NY 14203, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FTD.0b013e31821d3adbDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120966PMC
June 2011

Advocacy Recruiting for Huntington's Disease Clinical Trials.

PLoS Curr 2011 Apr 12;3:RRN1230. Epub 2011 Apr 12.

Huntington's Disease Drug Works; Evergreen Neuroscience Institute; Northwest Chapter Huntington's Disease Society of America; Huntington's Disease Society of America and University of Rochester Medical Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/currents.RRN1230DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082401PMC
April 2011

Alternative therapies for Clostridium difficile infections.

Pharmacotherapy 2010 Dec;30(12):1266-78

Department of Pharmacy Practice, The State University of New York, Buffalo, New York 14626, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1592/phco.30.12.1266DOI Listing
December 2010

Multidrug resistance 1 polymorphisms and trough concentrations of atazanavir and lopinavir in patients with HIV.

Pharmacogenomics 2007 Mar;8(3):227-35

University at Buffalo, Pharmacotherapy Research Center, School of Pharmacy and Pharmaceutical Sciences, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/14622416.8.3.227DOI Listing
March 2007